AJP - Endocrinology and Metabolism, Vol 262, Issue 1 E14-E19, Copyright © 1992 by American Physiological Society

ARTICLES

Hypertension without peripheral insulin resistance in spontaneously hypertensive rats

T. A. Buchanan, G. F. Sipos, N. Madrilejo, C. Liu and V. M. Campese
Department of Medicine, University of Southern California Medical School, Los Angeles 90033.

We performed euglycemic clamp studies with labeled glucose to measure insulin's effect on hepatic glucose output (HGO) and peripheral glucose clearance in eight conscious mobile spontaneously hypertensive rats (SHR) and eleven normotensive Wistar-Kyoto (WKY) rats age 9-10 wk. Systolic blood pressure was elevated in the SHR (P less than 0.001), whereas means of 12-h-fasted plasma insulin (P greater than 0.4), glucose (P greater than 0.07), HGO (P greater than 0.25), and glucose clearance (P greater than 0.2) did not differ significantly between groups. Infusions of human insulin into SHR and WKY rats (1 and 1.5 mU.min-1.kg-1, respectively) during concomitant somatostatin administration reestablished basal insulinemia in both groups. Neither HGO (P greater than 0.15) nor glucose clearance (P greater than 0.3) differed significantly between SHR and WKY rats under those conditions. Somatostatin plus higher-dose insulin infusions (4 mU.min-1.kg-1 in SHR and 3 or 6 mU.min-1.kg-1 in WKY rats) resulted in physiological hyperinsulinemia in all rats. Insulin sensitivity, calculated as the increase in glucose clearance effected by an increase in circulating insulin during higher-dose insulin infusions, did not differ significantly between SHR and WKY groups (P greater than 0.3). HGO was completely suppressed in SHR and WKY rats during the higher-dose insulin infusions. Our data indicate that hypertension is present in SHR at an age when insulin-mediated glucose disposal is not different from age-matched WKY rats. These findings do not support a role for peripheral insulin resistance in the genesis of hypertension in SHR.

This article has been cited by other articles:

				P. Ruggeri, A. Brunori, C. E. Cogo, D. Storace, F. Di Nardo, and R. Burattini Enhanced sympathetic reactivity associates with insulin resistance in the young Zucker rat Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R376 - R382. [Abstract] [Full Text] [PDF]

				N. Gaudreault, M. Santure, A. Nadeau, and H. Bachelard Isradipine and insulin sensitivity in hypertensive rats Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1038 - E1048. [Abstract] [Full Text] [PDF]

				J.-Y. Park, C.-H. Kim, S. K. Hong, K. I. Suh, and K.-U. Lee Effects of FFA on insulin-stimulated glucose fluxes and muscle glycogen synthase activity in rats Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E338 - E344. [Abstract] [Full Text] [PDF]

				J. K. Wi, J. K. Kim, and J. H. Youn Reduced glucose clearance as the major determinant of postabsorptive hyperglycemia in diabetic rats Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E257 - E264. [Abstract] [Full Text] [PDF]

				T. A. Kotchen Attenuation of Hypertension by Insulin-Sensitizing Agents Hypertension, August 1, 1996; 28(2): 219 - 223. [Full Text]

				L. A. Sechi, C. A. Griffin, G. Giacchetti, L. Zingaro, C. Catena, E. Bartoli, and M. Schambelan Abnormalities of Insulin Receptors in Spontaneously Hypertensive Rats Hypertension, April 1, 1996; 27(4): 955 - 961. [Abstract] [Full Text]